O'Malley, David M <br/><br/>
Weekly topotecan in heavily pretreated patients with recurrent epithelial ovarian carcinoma.  [electronic resource] 

 -  Gynecologic oncology  Aug 2005 
 - 242-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0090-8258 
<br/><br/><label>Standard No.: </label>10.1016/j.ygyno.2005.04.032  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--adverse effects<br/>Drug Administration Schedule<br/>Epithelial Cells--pathology<br/>Female<br/>Humans<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Ovarian Neoplasms--drug therapy<br/>Retrospective Studies<br/>Topotecan--administration & dosage